ReviewFrontiers in oncology2021

Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer.

Dan Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.